Auxo Firm Directory · Independent Research Profile

Littlejohn Co

Littlejohn describes an integrated platform spanning private equity, credit, and capital solutions. Its private equity criteria include $15M – $125M of EBITDA and an equity check of $75M – $500M.

Key takeaway

What stands out about Littlejohn Co

Littlejohn publicly targets North American middle-market companies in industrials and services, with private equity criteria of $15M – $125M in EBITDA and an equity check of $75M – $500M. It cites buyouts, corporate carve-outs, follow-on acquisition opportunities, and proven management among its deal attributes.[1][2][3][4][5][6][7][8]

What does Littlejohn Co invest in?

Littlejohn & Co., LLC is a Greenwich, Connecticut-based investment firm founded in 1996. It describes itself as an integrated private equity and credit investor focused on North American middle-market industrial and services companies.

The firm’s platform comprises private equity, credit, and capital solutions. Its materials describe differentiated deal structures and customized, hands-on value-creation playbooks.[1][2]

Littlejohn’s private equity strategy seeks to identify, invest in, and support companies through transformational growth. The firm states that it partners with families, founders, and management teams.

Its stated approach includes flexible or differentiated deal structures, integrated private equity and special situations capabilities, and customized hands-on value-creation playbooks.[1][3]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

EBITDAPublicly stated range
Lower published point$15M
Upper published point$500M

Published criteria: Littlejohn's private equity target criteria include EBITDA of $15M – $125M and an equity check of $75M – $500M.[3]

What should a business owner evaluate before considering a transaction with Littlejohn Co?

An owner evaluating Littlejohn can compare the company’s profile with the firm’s stated North American middle-market focus, industrials and services sectors, EBITDA target of $15M – $125M, and equity-check range of $75M – $500M. The firm also identifies buyouts, corporate carve-outs, follow-on acquisition opportunities, and proven management among its deal attributes.

Because the Milrose and 80/20 acquisition announcements do not disclose transaction terms, the PlayPower sale announcement does not disclose financial terms, and the PatientPoint exit announcement does not disclose transaction terms, an owner should request specific information on valuation methodology, leverage, seller rollover equity, governance rights, ownership duration, management incentives, operating resources, add-on acquisition criteria, and the proposed investment vehicle.[2][3][5][6][7][8]

01

What portion of the proposed equity would be primary versus secondary consideration

The Milrose and 80/20 acquisition announcements and the PatientPoint exit announcement do not disclose transaction terms, so the proposed consideration structure should be requested directly.[5][6][8]
02

What leverage and minimum cash-flow requirements would apply

The Milrose and 80/20 acquisition announcements do not disclose transaction terms, while the PlayPower sale and PatientPoint exit announcements do not disclose financial or transaction terms.[5][6][7][8]
03

How much seller rollover equity is expected, and what governance rights would accompany it

The Milrose and 80/20 acquisition announcements and the PatientPoint exit announcement do not disclose transaction terms, leaving these elements to be clarified directly.[5][6][8]

What companies does Littlejohn Co target?

Littlejohn’s private equity target criteria include EBITDA of $15M – $125M and an equity check of $75M – $500M.

The firm lists good-to-great buyouts, market-leading positions, follow-on acquisition opportunities, favorable secular industry trends, EBITDA growth and margin potential, corporate carve-outs, and proven management as deal attributes and structuring considerations.[3]

Littlejohn focuses on industrials and services. Its listed industrial areas include industrial products and manufacturing, building and infrastructure products, and value-added distribution. Listed services areas include business services, professional services, healthcare services, and transportation and logistics.[2]

Littlejohn states that it is focused on North American middle-market industrial and services companies.[1]

Littlejohn’s published criteria include both buyouts and follow-on acquisition opportunities. Its official investments page presents current and realized portfolio investments, including 80/20, RailPros, Brown Jordan, Saatva, Stallion Infrastructure Services, Benevis, Clean Earth, and Soundview Maritime.

The sources cited for this profile do not establish how the firm distinguishes platform investments from add-on acquisitions in every case.[3][4]

Littlejohn’s official investments page presents selected current and realized investments, including 80/20, RailPros, Brown Jordan, Saatva, Stallion Infrastructure Services, Benevis, Clean Earth, and Soundview Maritime.

The investments page states that the displayed investments are illustrative, do not include all investments made, and do not constitute a full list of the firm’s investments and returns.[4]

On June 3, 2026, Littlejohn announced that it had acquired Milrose Consultants from Southfield Capital; the announcement states that transaction terms were not disclosed. On February 3, 2026, it announced that it had acquired 80/20 from MPE Partners; that announcement also states that transaction terms were not disclosed.

On September 15, 2025, Littlejohn announced the sale of PlayPower to Platinum Equity, with financial terms not disclosed. On August 25, 2025, it announced its exit from PatientPoint to Advent International as part of an investor group led by L Catterton and Littlejohn; transaction terms were not disclosed.[5][6][7][8]

What is not clear from Littlejohn Co's public investment criteria?

The official investments page states that its selected investments are illustrative, do not include all investments made, and do not constitute a full list of the firm’s investments and returns.

The Milrose and 80/20 acquisition announcements do not disclose transaction terms. The PlayPower sale announcement does not disclose financial terms, and the PatientPoint exit announcement does not disclose transaction terms.[4][5][6][7][8]

Questions to ask when evaluating Littlejohn Co as a buyer or investment partner

What portion of the proposed equity would be primary versus secondary consideration?
The Milrose and 80/20 acquisition announcements and the PatientPoint exit announcement do not disclose transaction terms, so the proposed consideration structure should be requested directly.[5][6][8]
What leverage and minimum cash-flow requirements would apply?
The Milrose and 80/20 acquisition announcements do not disclose transaction terms, while the PlayPower sale and PatientPoint exit announcements do not disclose financial or transaction terms.[5][6][7][8]
How much seller rollover equity is expected, and what governance rights would accompany it?
The Milrose and 80/20 acquisition announcements and the PatientPoint exit announcement do not disclose transaction terms, leaving these elements to be clarified directly.[5][6][8]
Does Littlejohn expect a control position, and how would management incentive equity be structured?
Littlejohn lists buyouts among its deal attributes and states that it partners with families, founders, and management teams; the proposed control and incentive structure should be confirmed for the specific transaction.[3]
What is the anticipated ownership duration or exit approach for this investment?
The Milrose and 80/20 acquisition announcements do not disclose transaction terms, and the PatientPoint exit announcement does not disclose transaction terms. Ownership duration and exit approach should be confirmed for the proposed investment.[5][6][8]
Which operating partners and portfolio-support resources would be assigned?
Littlejohn describes customized hands-on value-creation playbooks; the resources assigned to a specific investment should be identified.[1]
How does the firm evaluate add-on acquisitions and integration risk?
Littlejohn lists follow-on acquisition opportunities among its deal attributes, while the published criteria do not specify the evaluation process for a particular company.[3]
Which fund or investment vehicle would make the investment, and what are the vehicle’s remaining commitment and deployment constraints?
The legal disclosures identify Littlejohn Fund VII Manager, L.P. and Littlejohn Fund VII-A, L.P. in connection with Regulation (EU) 2019/2088 disclosures; the proposed vehicle and its available commitments should be confirmed directly.[9]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Services / capabilities
  3. Investment strategy
  4. Transaction / portfolio evidence
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. Structure / regulatory context
  10. Structure / regulatory context
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.